The impact of improved delivery of ACTs will be undermined if the drugs are of suspect quality. This cuold be due to counterfeiting, substandard manufacturing or simply degradation due to poor or prolonged storage.
Useful resources | Peer-reviewed publications | Projects | News Poor quality malaria drugs: how many and where? (Research brief)
Research brief
Medicamentos para a malária de má qualidade: quantos são e onde estão? (Resumo da Evidência)
Resumo da Evidncia
Médicaments antipaludéens de mauvaise qualité : Combien en existe-t-il et où les trouve-t-on? (research brief)
Research Brief
Treatment guided by rapid diagnostic tests for malaria in Tanzanian children: safety and alternative bacterial diagnoses
Malaria Journal
The primacy of public health Considerations in defining poor quality medicines
PLos Medicine
Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia
Malaria Journal
Quality of artemisinin-containing antimalarials in Tanzania’s private sector— Results from a nationally representative outlet survey
American Journal of Tropical Medicine and Hygiene - Supplement on the Pandemic of Falsified Medicines
Quality of antimalarials at the epicenter of antimalarial drug resistance: Results from an overt and mystery client survey in Cambodia
American Journal of Tropical Medicine and Hygiene - Supplement on the Pandemic of Falsified Medicines
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
Lancet
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority
Malaria Journal
Fake anti-malarials: start with the facts
Malaria Journal
Degradation of Artemisinin-Based Combination Therapies Under Tropical Conditions
The American Society of Tropical Medicine and Hygiene
Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveys.
Tropical Medicine & International Health
Antimalarial drug quality: methods to detect suspect drugs
Future Medicine
A tiered analytical approach for investigating poor quality emergency contraceptives
PLOS ONE
Analysing the quality and authenticity of ACT drugs
[Project summary in Français / Português]
Scientific [Project summary in Français / Português] Scientific Access and quality of malaria diagnosis and treatment in South-East Asia
News
World Malaria Report 2013: Major progress against disease 'still fragile'
Malaria deaths have declined by 45% globally since 2000 - thanks to prevention and control measures, political commitment and expanded funding. But improving access to diagnosis andUne étude réalisée au Nigéria révèle qu’un médicament antipaludéen sur dix est de mauvaise qualité
L’étude approfondie de plus de 3 000 médicaments antipaludéens achetés à Enugu, au Nigéria, a révélé que 9,3 % d’entreSubstandard and falsified medicines: Day 3 at ECTMIH
The ACT Consortium drug quality programme shared findings on antimalarial sampling and analysis in a session dedicated to the surveillance of poor quality medicines.Study in Nigeria finds 1 in 10 malaria drugs are poor quality
A rigorous analysis of more than 3,000 antimalarials purchased in Enugu, Nigeria found 9.3% to be of poor quality, according to new research published in PLOS ONE. Substandard medicinesNew publication summarises ACT Consortium findings
"Answering key questions on malaria" is the lay summary of 25 research studies in 10 coutries in Africa and Asia. It is now available to the public at no cost, in English,Message from our Director - end of 2013
As we wrap up the year, Professor David Schellenberg shares news of recent developments and plans for 2014 in the ACT Consortium.Malaria drug resistance a potential 'global disaster'
Malaria experts from the World Health Organization Western Pacific Region and key partners are reiterating a warning that anti-malarial drug resistance is an ever-growing challengeLes traitements falsifiés du paludisme pas aussi courants que ce qui avait été auparavant signalé
Les chercheurs se réjouissent des résultats rassurants mais font remarquer que les médicaments de mauvaise qualité demeurent un problème.Improving delivery of malaria treatments
Professor David Schellenberg, Director of the ACT Consortium, discusses their work to improve the way artemisinin-based combination therapies are used to treat malaria, as well as theHelp us improve malaria diagnosis and treatment
The ACT Consortium will announce, in Addis Ababa, activities to help improve malaria diagnosis and treatment. The Ethiopian capital will host the first international summit on SocialFake malaria medicines: experts gather in Geneva
Drug quality specialists discussed prevention and surveillance methods to tackle the risks posed by poor quality medicines. The "Fake antimalarials: Start with the facts"Fake malaria drugs not as common as previously reported
A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research published in the American JournalFake antimalarials: meeting in Geneva, Switzerland on 28 May
The ACT Consortium will host a drug quality meeting entitled "Fake antimalarials: start with the facts" on 28th May 2015 in Geneva, Switzerland. Deadline to RSVP is 8 May.Estudo realizado na Nigéria conclui que 1 em 10 medicamentos para a malária são de fraca qualidade
Após uma análise rigorosa a mais de 3.000 medicamentos para a malária comprados em Enugu, na Nigéria, concluiu-se que 9,3% eram de fraca qualidade, de acordoEffective malaria control dramatically reduces deaths
The number of people dying from malaria has fallen dramatically since 2000 and malaria cases are also steadily declining, according to the World Malaria Report 2014. Experts highlightASTMH 2014: Malaria highlights
Bill Gates' announcement to increase malaria funding, strategic plans from the WHO to eliminate malaria and ACT Consortium research results were some of the malaria contributions seenACT Consortium researchers present at ASTMH 2014
The 63rd annual meeting of the American Society of Tropical Medicine and Hygiene takes place between 2-6 November in New Orleans, USA. Find out which research results we will presentAccess, targeting, safety and quality of ACT drugs at malaria conference
Delegates debated policy implications for the use of malaria rapid diagnostic tests (RDTs) in the public and private health sectors. ACT Consortium members presented research results